Navigation Links
Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
Date:7/20/2009

CAMBRIDGE, Mass., July 20 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today reported unaudited financial results for the second quarter and six months ended June 30, 2009. At June 30, 2009, Idenix's cash, cash equivalents and marketable securities totaled $51.7 million.

Business Highlights

  • Idenix announced today that it had successfully completed a proof-of-concept study of its lead HCV antiviral development program, IDX184, a novel once-daily liver-targeted nucleotide prodrug. This double-blind, placebo-controlled, monotherapy, dose-escalation study in HCV genotype-1-infected patients evaluated the safety and antiviral activity of IDX184. For more information on the results of this study, please see the related press release issued today by Idenix.
  • The company continued to advance its two preclinical HCV antiviral programs. Idenix is finalizing IND- or CTA-enabling preclinical studies for IDX375, a non-nucleoside polymerase inhibitor, and is preparing documentation to support initial regulatory filings. The company has synthesized the first kilogram of its lead protease inhibitor drug candidate and has initiated 28-day chronic toxicology studies in two species to support regulatory applications.
  • Finally, during the quarter, Idenix streamlined operations with the closure of its screening facility in Cagliari, Italy. This activity is now being performed at the company's laboratory in Cambridge, Massachusetts. As a result, Idenix reduced its workforce by 18 employees and incurred a restructuring charge in the quarter of $1.5 million.

"Our focus this year has been on the advancement of our HCV discov
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
2. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
3. Idenix Pharmaceuticals Reports First Quarter Financial Results
4. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
5. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
6. Idenix Announces Data Presentations from Three HCV Discovery and Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)
7. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
8. Idenix to Host Conference Call Discussing Fourth Quarter 2008 Financial Results
9. Idenix Pharmaceuticals to Present at the JP Morgan 27th Annual Healthcare Conference
10. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
11. Idenix Pharmaceuticals Reports Third Quarter and Nine Month Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., , DURHAM, N.C., Nov. 25 /PRNewswire/...led the first energy-efficient, single-treatment w...om carbon nanotubes to Andhra Pradesh, Minister of...her leaders in Hyderabad, India today. Initial tes...IT) Kanpur, confirmed that the majority of the dri...
(Date:11/25/2009)... Ambassador to Speak at Eco...ronto, Canada (Vocus) November 25, 2009 -- Ambassa...Who: ,David Appia, French Ambassador for Internati...t in France Agency ,To view a biography of David A...Ambassador Appia is available to meet with press t...
(Date:11/25/2009)..., , MARKHAM, ON, Nov. 25 /PRNewswire/ - Cyto...ldt, PhD to its Board of Directors. Dr. Moldt will...ative on the Company,s Board. The number of Board ...e are very pleased to welcome Peter Moldt to the b...ience and guidance as Cytochroma continues to make...
(Date:11/25/2009)..., , NEW YORK, Nov. 25 ...rch report is available in its catalogue: ,, B...2013 ,, http://www.reportlinker.com/p0165503/...-2013.html ,, Brazil Bioethanol Market Analysi...report provides detailed analysis and forecasts of...
Breaking Biology Technology:North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
...icals, Boosts Oncology Pipeline With Up to Three P... Phase III in 2009, INDIANAPOLIS and NEW YO...d ImClone Systems Inc. (Nasdaq: IMCL ) today,anno...es have approved a,definitive merger agreement und... cash tender offer of $70.00 per share, or approxi...
...a Bethlehem, PA based pharmaceutical software and ...ew out-of-the-box labeling solution based on Docum...ation. SPL for DCM provides a complete labeling c...elease 4 submission standard mandated by the FDA, ...mily of pharmaceutical labeling solutions. , ...
...sciences, Inc. (Nasdaq: MGRM ) today announced th...Nasdaq Stock Market dated October 1, 2008,indicati...days, the bid,price of Monogram,s common stock has...ent for continued listing under Nasdaq rules., Th...will be provided,with 180 calendar days, or until ...
Other Biology Technology:Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 2Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 3Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 4Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 5Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 6Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 7Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 8Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 9Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 10Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 11Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 12Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 13Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 14Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 15Lilly to Acquire ImClone Systems in $6.5 Billion Transaction 16Glemser Announces New Labeling Solution: SPL for DCM Addresses New SPL Release 4 Requirements 2Monogram Receives NASDAQ Notification 2Monogram Receives NASDAQ Notification 3Monogram Receives NASDAQ Notification 4
(Date:11/25/2009)...er 11, firefighters, police officers and ambulance...orld Trade Center complex. They battled to save pe... survivors, tackled fires and evacuated as many pe...stimated 17,000 people. And making their jobs even...ightened workers and their relatives jammed mobile...
(Date:11/25/2009)...I, NOVEMBER 25, 2009 Soil is the linchpin of the ...osphere meet. Despite that, many students see soil...ng more. Soil science educators are challenged wit...gnize the critical importance of soil in the envir...ce and earth science teachers at University of Neb...
(Date:11/25/2009)...tate University assistant professors recently rece...(NSF) to continue research beneficial to understan...000. , Christopher Blackwood, assistant professo...arded grants to support two separate research proj...tter Decomposer Communities and Functions from the...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2Sinovac Obtains Production License for H1N1 Vaccine 13826 1Sinovac Obtains Production License for H1N1 Vaccine 13826 2Sinovac Obtains Production License for H1N1 Vaccine 13826 3Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 1Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 2Desire for Youthful Appearance Will Drive the North American Laser Assisted Liposuction Device Market Through 2013 According to Millennium Research G 56127 3Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 1Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 2Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 3Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 4Endo Pharmaceuticals Introduces VALSTAR 28TM 29 28Valrubicin 29 To Fill Unmet Need In Aggressive Form of Bladder Cancer 56122 5
...ew technique for printing extraordinarily thin lin...ess expensive and more versatile electronic displa...technologies. , Solving a fundamental and long-st...eveloped a method for shooting stable jets of elec...echnique, which produced lines just 100 nanometers...
...llions of nearly invisible wires may hold the answ...of alternative energy. , The Department of Engine...nergy and the Ontario Centres of Excellence (OCE) ...ization of nanowire technology in the production o...technology developed at McMaster is able to trap m...
...logists from the University of Leicester propose t... brought about an end to one epoch of Earths histo...asiewicz and Mark Williams at the University of Le...ommission of the Geological ,Society of London hav...y. , In it, they suggest humans have so changed t...
Other Biology News:Fine print: New technique allows fast printing of microscopic electronics 2Fine print: New technique allows fast printing of microscopic electronics 3Nanowires hold promise for more affordable solar cells 2Man-made changes bring about new epoch in Earth's history 2
Mouse Anti-Bcr-abl Monoclonal Antibody, Unconjugated, Clone 7C6 from Abcam
Rabbit Anti-Bcl-G, C-Terminus Polyclonal Antibody, Unconjugated from AnaSpec
Rat Anti-Mouse IgM Heavy Chain Monoclonal Antibody, FITC Conjugated, Clone LO-MM-9 from Cell Sciences
Anti-TIMP-4 (Tissue Inhibitor of Metalloproteinases-4), Loop #3 Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: